Detalhe da pesquisa
1.
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy.
Blood
; 142(24): 2079-2091, 2023 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595362
2.
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs.
Blood
; 134(2): 160-170, 2019 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043423
3.
PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells.
Blood
; 132(11): 1095-1105, 2018 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954749
4.
Increased mitochondrial apoptotic priming with targeted therapy predicts clinical response to re-induction chemotherapy.
Am J Hematol
; 95(3): 245-250, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31804723
5.
Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell-dependent cytotoxicity.
Blood
; 129(16): 2246-2256, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28137826
6.
Inhibition of USP10 induces degradation of oncogenic FLT3.
Nat Chem Biol
; 13(12): 1207-1215, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28967922
7.
miR-181a negatively regulates NF-κB signaling and affects activated B-cell-like diffuse large B-cell lymphoma pathogenesis.
Blood
; 127(23): 2856-66, 2016 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26941399
8.
Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma.
Blood
; 128(2): 239-48, 2016 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27151888
9.
Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma.
Blood
; 126(13): 1555-64, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26194763
10.
CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma.
Blood
; 122(7): 1233-42, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23838350
11.
miR-155 regulates HGAL expression and increases lymphoma cell motility.
Blood
; 119(2): 513-20, 2012 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22096245
12.
Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.
Blood
; 119(23): 5478-91, 2012 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22517897
13.
Red Blood Cells as Therapeutic Target to Treat Sickle Cell Disease.
Antioxid Redox Signal
; 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37975291
14.
Therapeutic biomarkers in acute myeloid leukemia: functional and genomic approaches.
Front Oncol
; 14: 1275251, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410111
15.
Understanding the complex formation of falstatin; an endogenous macromolecular inhibitor of falcipains.
Int J Biol Macromol
; 265(Pt 1): 130420, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460641
16.
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts.
Blood Cancer Discov
; 5(3): 180-201, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38442309
17.
Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.
Proc Natl Acad Sci U S A
; 107(29): 13069-74, 2010 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20615981
18.
A novel single sensor hemoglobin domain from the thermophilic cyanobacteria Thermosynechococcus elongatus BP-1 exhibits higher pH but lower thermal stability compared to globins from mesophilic organisms.
Int J Biol Macromol
; 240: 124471, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076076
19.
CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response.
Leukemia
; 37(2): 359-369, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473980
20.
Suramin, penciclovir, and anidulafungin exhibit potential in the treatment of COVID-19 via binding to nsp12 of SARS-CoV-2.
J Biomol Struct Dyn
; 40(24): 14067-14083, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784490